小细胞肺癌的临床用药方案现状及潜在靶点药物治疗方案新进展 点击下载
论文标题: 小细胞肺癌的临床用药方案现状及潜在靶点药物治疗方案新进展
英文标题:
中文摘要: 小细胞肺癌(SCLC)约占肺癌的15%,恶性程度高,异质性和侵袭性均较强。依托泊苷联合铂类是广泛期SCLC标准一线治疗的基础,但存在易耐药、易复发的问题。近年来,新型免疫药物和新型细胞毒性药物的出现在一定程度上提高了SCLC患者的生存率,为复发/难治型SCLC患者带来了治疗希望。本文通过综述SCLC临床用药方案的现状和潜在靶点药物治疗方案的新进展发现,目前SCLC一、二、三线方案包括依托泊苷+卡铂、阿替利珠单抗+依托泊苷+铂类药物、阿得贝利单抗、拓扑替康、多西他赛等,作用靶点主要集中在拓扑异构酶Ⅱ/Ⅰ、DNA、免疫检查点分子程序性死亡受体1/程序性死亡受体配体1、微管蛋白等;潜在靶点药物治疗方案包括阿立塞替+紫杉醇、洛伐妥珠单抗、APG-1252等,作用靶点主要集中在DNA损伤应答通路和免疫通路,可通过极光激酶A等多种潜在靶点来发挥抗肿瘤作用,实现延长患者生存期的治疗目标。
英文摘要: Small cell lung cancer (SCLC) accounts for about 15% in lung cancer and is highly malignant, heterogeneous and invasive. Etoposide combined with platinum-based chemotherapy is the basis of standard first-line treatment for extensive-stage SCLC, but suffers from the problem of susceptibility to drug resistance and relapse. In recent years, the emergence of new immunological drugs and novel cytotoxic drugs has improved the survival of SCLC patients to a certain extent, especially bringing therapeutic hope to patients with relapsed/refractory SCLC. In this paper, we review the current clinical drug regimens and the new progress of potential target drug therapeutic regimens for the treatment of SCLC. At present, the first-, second- and third-line schemes of SCLC include etoposide+carboplatin, atezolizumab+etoposide+platinum, adebrelimab, topotecan, docetaxel, etc.; the current drug targets for the treatment of SCLC mainly focus on topoisomerase Ⅱ/Ⅰ, DNA, the immune checkpoint molecules programmed death-1/programmed death-ligand 1, tubulin, etc. The potential target drug therapeutic options include alisertib+ paclitaxel, rovalpituzumab, APG-1252, etc., and mainly focus on DNA damage response pathways and immune pathways, which can achieve the prolongation of patient survival by exerting anti-tumor effects through aurora kinase A and other potential targets.
期刊: 2023年第34卷第16期
作者: 章欢琪;林旭;沈姝颖;李杨玲
英文作者: ZHANG Huanqi,LIN Xu,SHEN Shuying,LI Yangling
关键字: 小细胞肺癌;化疗;免疫治疗;作用靶点;潜在靶点药物治疗方案
KEYWORDS: small cell lung cancer; chemotherapy; immunotherapy; therapeutic targets; potential target drug therapeutic options
总下载数: 81次
本日下载数: 2次
本月下载数: 81次
文件大小: 619.60Kb

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!